(IN BRIEF) Cyted Health has raised USD 44 million in Series B financing led by EQT Life Sciences with participation from Advent Life Sciences, the British Business Bank, Morningside, BGF, and HCA Healthcare. The funds will accelerate Cyted’s commercial rollout … Read the full press release →
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, Netherlands, News, Science, Sweden, Technology, United Kingdom
Tagged Advent Life Sciences, BGF, biomarker testing, British Business Bank, Bruno Holthof, Cyted Health, EndoSign, EQT Life Sciences, esophageal cancer, gastroenterology, gastrointestinal diagnostics, HCA Healthcare, Marcel Gehrung, Morningside, NHS, oncology, partnership, Series B funding, sustainability, University of Cambridge, US expansion